Abstract Methamphetamine (METH) induces stereotypy, which is characterized as inflexible, repetitive behavior. Enhanced activation of the patch compartment of the striatum has been correlated with stereotypy, suggesting that stereotypy may be related to preferential activation of this region. However, the specific contribution of the patch compartment to METH-induced stereotypy is not clear. To elucidate the involvement of the patch compartment to the development of METH-induced stereotypy, we determined if destruction of this sub-region altered METHinduced behaviors. Animals were bilaterally infused in the striatum with the neurotoxin dermorphin-saporin (DERM-SAP; 17 ng/ll) to specifically ablate the neurons of the patch compartment. Eight days later, animals were treated with METH (7.5 mg/kg), placed in activity chambers, observed for 2 h and killed. DERM-SAP pretreatment significantly reduced the number and total area of mulabeled patches in the striatum. DERM-SAP pretreatment significantly reduced the intensity of METH-induced stereotypy and the spatial immobility typically observed with METH-induced stereotypy. In support of this observation, DERM-SAP pretreatment also significantly increased locomotor activity in METH-treated animals. In the striatum, DERM-SAP pretreatment attenuated METH-induced c-Fos expression in the patch compartment, while enhancing METH-induced c-Fos expression in the matrix compartment. DERM-SAP pretreatment followed by METH administration augmented c-Fos expression in the SNpc and reduced METH-induced c-Fos expression in the SNpr. In the medial prefrontal, but not sensorimotor cortex, c-Fos and zif/268 expression was increased following METH treatment in animals pre-treated with DERM-SAP. These data indicate that the patch compartment is necessary for the expression of repetitive behaviors and suggests that alterations in activity in the basal ganglia may contribute to this phenomenon.
Introduction
The striatum is a component of the basal ganglia that is critically important in the regulation of movement and alterations in the function of the striatum contribute to the development of movement disorders (Crittenden and Graybiel 2011) . The striatum can be divided into the patch (striosome) and matrix compartments that are delineated based on their differential expression of neuropeptides and receptors, as well as their connectivity (Crittenden and Graybiel 2011; Gerfen et al. 1985; Gerfen and Wilson 1996; Gerfen and Young 1988; Graybiel 1990) . For example, the patch compartment receives input from limbic regions, such as the prelimbic cortex and amygdala, while the matrix compartment receives input from sensorimotor and associative forebrain regions (Bolam et al. 1988; Gerfen 1984; McDonald 1992; Ragsdale and Graybiel 1988) . The specific functions of these compartments are not completely understood, but several lines of data, including metabolic studies (Brown et al. 2002) , intracranial self-stimulation studies (White and Hiroi 1998) , and enhanced immediate early gene activity (Canales and Graybiel 2000; Graybiel et al. 1990; Horner et al. 2010; Moratalla et al. 1992; Tan et al. 2000; and neuropeptide expression (Adams et al. 2003; Fagergren et al. 2003; Horner et al. 2010; in the patch versus matrix compartments following psychostimulant treatment indicate that the patch and matrix compartments may sub-serve different aspects of motor activity and behavior.
Stereotypy is defined as the development of abnormally repetitive motor actions that coincides with an inability to initiate normal adaptive responses, and can occur as a result of treatment with high or repeated doses of psychostimulants, such as methamphetamine (METH) (Canales and Graybiel 2000; Graybiel et al. 1990; Graybiel and Rausch 2000; Horner et al. 2010) . It has been suggested that psychostimulant-induced stereotypic behaviors may be related to enhanced activation of the patch compartment relative to the surrounding matrix compartment, as the relative degree of c-Fos expression in the patch compartment in rostral striatum correlates with the development of stereotypic behavior following psychostimulant treatment (Canales and Graybiel 2000) . Interestingly, this relationship was specific for the rostral aspects of striatum, as there was no significant correlation between psychostimulant-induced patch-enhanced c-Fos expression and stereotypy in mid-level striatum (Canales and Graybiel 2000) . While recent data suggest that an imbalance in the medial prefrontal and sensorimotor circuits that transverse the striatum may also contribute to psychostimulant-induced stereotypy (Aliane et al. 2009 ), the precise role of patch-based circuits in the development of stereotypic behaviors in response to psychostimulant treatment is not clear.
To address the role of the neurochemically distinct patch compartment in the genesis of psychostimulant-induced stereotypy, we utilized the neurotoxin dermorphin-saporin (Lawhorn et al. 2009; Tokuno et al. 2002) to specifically ablate the neurons that comprise the patch compartment prior to METH treatment. The neurons of the patch compartment express a high density of mu opioid receptors, while the neurons of the matrix compartment contain relatively few mu opioid receptors (Herkenham and Pert 1981; Pert et al. 1976; Tempel and Zukin 1987) . Dermorphin is a potent mu opioid receptor agonist that induces internalization of mu opioid receptors upon binding (Giagnoni et al. 1984) , while saporin is a ribosome-inactivating cytotoxin (Wiley and Kline 2000) . Thus, internalization of the DERM-SAP complex will ultimately lead to the destruction of mu opioid receptor-containing neurons (such as those found in the patch compartment of striatum), while leaving non-mu opioid receptor expressing neurons (such as the majority of those found in the matrix) relatively intact.
The goal of this study was to determine whether preferential ablation of the patch compartment altered the development of stereotypic behavior following a high dose of methamphetamine. We then examined the impact of patch compartment lesions on METH-induced c-Fos expression in the patch and matrix compartments of rostral striatum, as well as in the nucleus accumbens. We also examined whether ablation of patch-based circuits would alter METH-induced c-Fos activity in substantia nigra pars compacta (SNpc), which receives specific input from the patch compartment, and provides dopaminergic input to the striatum (Fujiyama et al. 2011; Gerfen et al. 1985; Jimenez-Castellanos and Graybiel 1989; Tokuno et al. 2002) . Finally, in order to determine if ablation of the patch compartment might have an impact on basal ganglia output, we examined METH-induced c-Fos activation in the substantia nigra pars reticulata (SNpr), the main output nucleus of the basal ganglia, as well as c-Fos activation and zif/268 mRNA expression in the frontal cortex, the ultimate target of basal ganglia-based circuits (Gerfen 1984; Gerfen and Wilson 1996) .
Materials and methods

Animals
Male Sprague-Dawley rats (Harlan Laboratories, Indianapolis, IN, USA), weighing 250-350 g were used in all experiments. Rats were housed in groups of four in plastic cages in a temperature-controlled room. Rats were on a 14:10 h light/dark cycle and had free access to food and water. All animal care and experimental manipulations were approved by the Institutional Animal Care and Use Committee of Mercer University School of Medicine and were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The minimum possible number of animals (based on power analyses) was used for our experiments and steps were taken to minimize any suffering that might occur during our procedures.
Drugs and chemicals (±)METH hydrochloride was a generous gift from the National Institute on Drug Abuse (Bethesda, MD, USA). Ketamine hydrochloride and xylazine hydrochloride were obtained from Sigma-Aldrich (St. Louis, MO, USA). Methamphetamine, ketamine and xylazine doses were calculated as the free base and dissolved in normal saline. All drugs were given in a volume of 1 ml/kg. Dermorphinsaporin (DERM-SAP) and unconjugated saporin (SAP) were obtained from Advanced Targeting Systems (San Diego, CA, USA) and dissolved in buffered artificial cerebrospinal fluid (aCSF: 144 mM NaCl, 2.68 mM KCl, 1.6 mM CaCl 2 , 2.6 mM MgCl 2 , 0.4 mM KH 2 PO 4 , pH 7.2).
DERM-SAP infusion
Rats were anesthetized with ketamine (90 mg/kg, i.p.) and xylazine (9 mg/kg, i.p.) and fixed on a stereotaxic frame (Stoelting Company, Wood Dale, IL, USA). The skull was exposed and a burr hole was drilled through the skull to introduce a 29-gauge needle for the infusion. A total volume of 2 ll of DERM-SAP (17 ng/ll; Tokuno et al. 2002) or the equivalent amount of unconjugated SAP (as a control; Tokuno et al. 2002) was infused bilaterally into the rostral striatum (coordinates based on bregma: ?1.7 mm anterior, 2.6 mm lateral, -5.0 mm ventral; Paxinos and Watson 2005) at a rate of 0.5 ll/min. The needle was left in place for 5 min following the infusion and slowly removed to minimize fluid backflow. The animals were then returned to their home cage, where they were allowed to survive for 8 days (Tokuno et al. 2002) . Only animals whose infusions were in the rostral striatum were included in subsequent analyses.
Experimental design and behavior
Twenty-four hours prior to treatment with METH, animals were habituated to plexiglass activity chambers (46 9 46 9 12 cm on top of a 4 9 4 grid; Frankel et al. 2007; Horner et al. 2010 Horner et al. , 2012 by placing them in the chambers for 60 min, giving them sham injections and returning them to the chambers for 2 h. The next day, animals were placed in the chambers for 60 min, after which time they were injected with METH (7.5 mg/kg, s.c.) or saline and returned to the activity chambers for 2 h, during which time the behavior was digitally recorded for post-hoc analyses. During the post-hoc analyses, each animal's behavior was observed by an individual blind to the experimental conditions for 1 min every 5 min for the entire 2 h observation period after the injection of METH or saline. Stereotypy was rated on a scale of 1-10 (Table 1) , with 10 representing the highest degree of the response (Canales and Graybiel 2000; Horner et al. 2010 Horner et al. , 2012 . Stereotypy scores were generated by averaging the scores from four behavioral dimensions: repetitiveness/ flexibility (the number of alternative motor responses emitted), frequency (the number of responses per unit time), duration (the percentage of time spent performing the most dominant response(s)) and the spatial distribution of the motor response (Canales and Graybiel 2000) . Locomotor activity was defined by the number of quadrants the animal crossed on the 4 9 4 grid, and was converted into centimeters (Frankel et al. 2007 ).
Tissue processing for immunohistochemistry and in situ hybridization
Two hours (c-Fos) or three hours (zif/268 mRNA) after treatment with METH or saline, rats were killed by exposure to CO 2 for 1 min followed by decapitation. The brains were rapidly harvested, quick-frozen in isopentane on dry ice and stored at -80°C until they were cut into 12-lm sections through the prefrontal cortex (at approximately ?4.2 mm from bregma), striatum/nucleus accumbens (NAc; at approximately ?1.7 mm from bregma), and substantia nigra (at approximately -5.25 mm from bregma; Paxinos and Watson 2005) on a cryostat (Minotome Plus, Triangle Biomedical Sciences, Durham, NC, USA).
Mu opioid receptor immunohistochemistry
Sections through striatum were post-fixed in 4 % paraformaldehyde/0.9 % NaCl and then rinsed three times in 0.1 M phosphate-buffered saline (PBS). Slides were then blocked with 10 % bovine serum albumin (BSA)/0.3 % Triton X-100 (TX)/0.1 M PBS for 2 h followed by overnight incubation at 4°C with a polyclonal antibody for the mu opioid receptor (Immunostar, Hudson, WI, USA), diluted in 1:1,000 in 0.3 % TX/0.1 M PBS/5 % BSA. The slides were then washed several times in PBS and incubated 
c-Fos immunohistochemistry
Sections through prefrontal cortex, striatum/NAc and substantia nigra were post-fixed in 4 % paraformaldehyde, pH 7.4 and then rinsed three times in PBS. Slides were then blocked with 4 % normal goat serum (NGS)/0.3 % TX for 1 h followed by overnight incubation at 4°C with a polyclonal antibody for c-Fos (Abcam, Cambridge, MA, USA), diluted in 1:1,000 in 0.3 % TX/0.1 M PBS. The slides were then washed several times in PBS and incubated for 2 h at room temperature in biotinylated goat antirabbit IgG antiserum (Vector Laboratories) diluted 1:200 in 0.1 M PBS/1 % NGS. Slides were then washed three times in PBS, incubated 1 h in ABC solution (Elite ABC Kit, Vector Laboratories) and washed three more times in PBS. Bound antibody was detected using a 3,3
? solution (Vector Laboratories). Slides were washed with deionized H 2 O, dehydrated in a series of alcohols and coverslipped out of xylene.
Calbindin immunohistochemistry
Sections through striatum were post-fixed in 4 % paraformaldehyde, pH 7.4 and then rinsed three times in PBS. Slides were then blocked with 4 % NGS/0.3 % TX for 1 h followed by overnight incubation at 4°C with a polyclonal antibody for calbindin (Immunostar), diluted in 1:1,000 in 0.3 % TX/0.1 M PBS. The slides were then washed several times in PBS and incubated for 2 h at room temperature in biotinylated goat anti-rabbit IgG antiserum (Vector Laboratories) diluted 1:200 in 0.1 M PBS/1 % NGS. Slides were then washed three times in PBS, incubated 1 h in ABC solution (Elite ABC Kit, Vector Laboratories) and washed three more times in PBS. Bound antibody was detected using a 3,3 0 -diaminobenzidine/Ni ? solution (Vector Laboratories). Slides were washed with deionized H 2 O, dehydrated in a series of alcohols and coverslipped out of xylene.
Choline acetyltransferase (ChAT) immunohistochemistry
Sections through striatum were post-fixed in 4 % paraformaldehyde/0.9 % NaCl and then rinsed three times in 0.1 M PBS. Slides were then blocked with 10 % BSA/ 0.3 % TX/0.1 M PBS for 2 h followed by overnight incubation at 4°C with a polyclonal antibody for ChAT (AbCam), diluted in 1:1,000 in 0.3 % TX/0.1 M PBS/5 % BSA. The slides were then washed several times in PBS and incubated for 2 h at room temperature in biotinylated goat anti-rabbit IgG antiserum (Vector Laboratories, Burlingame, CA, USA) diluted 1:200 in 0.1 M PBS/5 % BSA. Slides were then washed three times in PBS, incubated 1 h in ABC solution (Elite ABC Kit, Vector Laboratories) and washed three more times in PBS. Bound antibody was detected using a 3,3 0 -diaminobenzidine/Ni ? solution (Vector Laboratories). Slides were washed with deionized H 2 O, dehydrated in a series of alcohols and coverslipped out of xylene.
In situ hybridization histochemistry Sections through prefrontal cortex were post-fixed in 4 % paraformaldehyde/0.9 % NaCl, acetylated in fresh 0.25 % acetic anhydride in 0.1 M triethanolamine/0.9 % NaCl (pH 8.0), dehydrated in alcohol, delipidated in chloroform and gradually re-hydrated in a descending series of alcohol concentrations. Slides were air-dried and stored at -20°C. An oligonucleotide probe (GeneDetect, Bradenton, FL, USA) complementary to bases 355-399 of zif/268 mRNA (Milbrandt 1987) was end-labeled with [
33 P]-dATP (Perkin Elmer NEN, Wellesley, MA, USA). Each probe was diluted in hybridization buffer (0.6 M sodium chloride, 80 mM Tris, 4 mM EDTA, 0.1 % w/v sodium pyrophosphate, 10 % w/v dextran, 0.2 % w/v lauryl sulfate, 0.5 mg/ml heparin, 50 % formamide) and 90 ll of the probe in hybridization buffer was applied to each slide and covered with glass coverslips. Slides were hybridized overnight in humid chambers at 37°C, followed by four washes in 19 saline-sodium citrate (SSC: 0.15 M NaCl, 0.015 M sodium citrate, pH 7.2) at room temperature and then three washes in 29 SSC with 50 % (v/v) formamide at 42°C. Slides were washed twice in 19 SSC at room temperature, dipped in deionized H 2 O and air-dried. All labeled slides were apposed to X-ray film (Kodak Biomax MR film, Eastman Kodak Company, Rochester, NY, USA) for approximately 30 days.
Image analysis
To confirm the loss of mu opioid receptor immunoreactive patches in the striatum, slides from mu opioid receptor immunohistochemistry were captured with a video camera (CCD IEEE-1394, Scion Corporation, Frederick, MD, USA). Patches of mu opioid receptor immunoreactivity were outlined using ImageJ software (National Institutes of Health; http://rsb.info.nih.gov/ij), in both the left and right hemispheres for the whole rostral striatum (10-16 animals per treatment group), designated as the area below the corpus callosum and above the anterior commissure, ending approximately at the ventral tip of the lateral ventricle at approximately ?1.7 mm anterior to bregma (see Fig. 1 ), and the number of patches in each hemisphere was counted and averaged. The number of mu opioid receptor-labeled patches that exceeded the threshold density was determined using the particle analysis option in ImageJ. Prior to analysis, the pixel range for patch size was determined by outlining approximately 5-15 positively labeled patches from 10 to 15 randomly selected sections and determining the average size of the labeled patches in terms of pixel area. The lower limit for a ''labeled patch'' on the particle analysis setting was then set to the smallest number of pixels measured for any patch, whereas the upper limit was set at the maximal particle size on the particle analysis option on ImageJ. The threshold density was adjusted such that background staining was eliminated and the number of mu-immunoreactive patches was measured above this threshold. To determine whether DERM-SAP treatment altered the overall size of the patch compartment, the total area, in pixels, of the mu-immunoreactive patches highlighted by thresholding in both the left and right hemispheres was averaged for each animal. Examination of the mean density of mu-immunoreactive staining was also examined to confirm the loss of the patch compartment. Basic densitometric analysis yielded average density (gray) values over the region of interest. Before the measurement of sections, the linearity of the video camera to increasing signal intensity was determined using the average gray value of signals of known optical density from a photographic step tablet (Eastman Kodak Company). The intensity of the light was adjusted such that values from the mu opioid receptor immunoreactive sections fell within the linear portion of the system's response. Lighting and camera conditions remained constant during the process of capturing and collecting density measurements. Regions containing mu opioid receptor staining were outlined using ImageJ software in the left and right hemispheres of the whole rostral striatum for each animal. The average gray value of the white matter overlying the striatum was subtracted from the average gray value of the region of interest to correct for background labeling in the left and right hemispheres and averaged for each animal. Measurements are given relative to bregma. The regions used for particle analysis of c-Fos immunoreactivity are highlighted in gray and consist of the medial prefrontal and sensorimotor cortices (?4.52 mm), core and shell of NAc (?1.7 mm) and SNpc and SNpr (-5.25 mm), while the region of striatum (?1.7 mm) used for particle analysis of ChAT immunoreactivity is unshaded. mPFC medial prefrontal cortex, SMC sensorimotor cortex, STR striatum, SNpc substantia nigra pars compacta, SNpr substantia nigra pars reticulata c Calbindin, which is preferentially expressed in the matrix versus the patch compartment (Gerfen et al. 1985) , was immunohistochemically labeled to confirm that the matrix compartment was intact following DERM-SAP pretreatment. Slides from calbindin immunohistochemistry were captured with a video camera (CCD IEEE-1394, Scion Corporation). Basic densitometric analysis yielded average density (gray) values over the region of interest, and the imaging parameters were determined as described above for mean density measurement of mu opioid receptor staining. Regions containing calbindin staining were outlined using ImageJ software in the left and right hemispheres of the whole rostral striatum for each animal. The average gray value of the white matter overlying the striatum was subtracted from the average gray value of the region of interest to correct for background labeling in the left and right hemispheres and averaged for each animal. In addition, the total area of the calbindin-labeled region of interest in both the left and right hemispheres was determined using ImageJ and averaged for each animal.
Choline acetyltransferase (ChAT) immunohistochemistry was utilized to determine whether cholinergic interneurons, a sub-population of which express mu opioid receptors (Jabourian et al. 2005) , were affected by DERM-SAP treatment. ChAT-labeled images (10-16 animals per treatment group) were captured from a VistaVision microscope (VWR, Radnor, PA, USA) with a video camera (CCD Moticam 2300, Motic, Richmond, BC, Canada), using a 109 objective. Immunoreactivity was measured in a 1,024 9 768 pixel square encompassing the left dorsal striatum (Fig. 1) and was based on previously described procedures (Choe et al. 2002; Horner et al. , 2011 Simpson et al. 1995) . The number of ChAT-labeled particles that exceeded the threshold density in each region of interest was determined using the particle analysis option in ImageJ. Prior to analysis, the pixel range for particle size was determined by outlining approximately 15-20 positively labeled cells from 10 to 15 randomly selected sections and determining the average size of the labeled cells in terms of pixel area. The lower limit for a ''labeled cell'' on the particle analysis setting was then set to the smallest number of pixels measured for any cell, whereas the upper limit was set at the maximal particle size on the particle analysis option on ImageJ. The threshold density was adjusted such that background staining was eliminated and the number of immunoreactive pixels per the selected area in each region of interest was measured above this threshold.
Pixel range determination and particle analysis of c-Fos immunoreactivity were performed as described above for ChAT. Briefly, images from the left hemisphere (5-8 animals per treatment group) were captured from a VistaVision microscope (VWR, Radnor, PA, USA) with a video camera (CCD Moticam 2300), using a 109 objective and c-Fos immunoreactivity measured in a 500 9 500 pixel square for the sensorimotor sub-region of prefrontal cortex, Fig. 2 Effects of DERM-SAP infusion on mu opioid receptor immunoreactivity in the striatum. Infusion with the neurotoxin DERM-SAP (17 ng/ll) resulted in a decrease in mu opioid receptor immunoreactivity in the striatum (a). DERM-SAP treatment significantly reduced the overall number of mu-labeled patches in the striatum (b), the total size of mu opioid receptor immunoreactive patches (c), and the mean density of mu opioid receptor immunoreactive staining (d), as compared to animals treated with unconjugated SAP. *p \ 0.05 vs. SAP-treated control animals a 500 9 600 pixel rectangle for the medial prefrontal cortex (mPFC), a 400 9 400 pixel square the core and shell of the NAc, and a 500 9 150 pixel oval for the SNpc and SNpr (Fig. 1) .
Sections adjacent to those used for c-Fos immunohistochemistry were labeled for calbindin immunohistochemistry to distinguish the patch and matrix compartments of striatum. Both c-Fos-labeled sections and adjacent calbindin-labeled sections from the left hemisphere were captured on a VistaVision (VWR) microscope with a video camera (CCD Moticam 2300) using a 2.59 objective. Image J was used to outline regions of either dense calbindin immunoreactivity (matrix) or absent calbindin immunoreactivity (patch) and which were superimposed over corresponding areas of the adjacent c-Fos-labeled striatal section and the number c-Fos-labeled particles counted in the region of interest, as described above. Counts of c-Fos-labeled particles were expressed as the number c-Fos-IR particles per mm 2 . For the analysis of zif/268 mRNA expression, film autoradiograms were analyzed using the image analysis program ImageJ, as previously described (Horner et al. 2012; . Zif/268-labeled autoradiographic films were from captured with a video camera (CCD IEEE-1394, Scion Corporation) and basic densitometric analysis yielded average density (gray) values over regions of interest, as described above for the analysis of mu opioid receptor and calbindin immunoreactivity. Images from the left prefrontal cortex from 5 to 8 animals per treatment group were analyzed for each region of interest examined. Measurements were made according to the coordinates of Paxinos and Watson (Paxinos and Watson 2005) in the medial prefrontal and sensorimotor cortices. The average gray value of the white matter overlying the structure being measured was subtracted from the average gray value of the region of interest to correct for background labeling.
Statistical analysis
A Student's t test was used to analyze the effects of DERM-SAP treatment, the number and total area of mu opioid receptor-labeled patches, the density of calbindin staining and the number of ChAT-immunoreactive particles in the striatum. The effects of DERM-SAP pretreatment on METH-induced c-Fos immunoreactivity and zif/ 268 mRNA expression were analyzed using a two-way (pretreatment 9 treatment) analysis of variance for each region of interest. Behavioral rating data were represented as the area under the curve (AUC) and was also analyzed using a two-way (pretreatment 9 treatment) analysis of variance. Post-hoc analysis of significant effects was accomplished using Tukey multicomparison tests. The alpha level for all analyses was set at 0.05.
Results
Effects of DERM-SAP infusion on mu opioid receptor immunoreactivity in the striatum
Infusion of DERM-SAP into striatum reduced mu opioid receptor immunoreactivity relative to infusion of unconjugated SAP (Fig. 2a) . A Student's t test revealed that DERM-SAP pretreatment significantly reduced the number of mu opioid receptor-labeled patches in the striatum (t = 8.0, p \ 0.0001; Fig. 2b ). An unpaired t test also revealed that DERM-SAP pretreatment significantly reduced the total area of patches present in the striatum (t = 9.8, p \ 0.0001; Fig. 2c ), as well as the mean density of mu opioid receptor immunoreactive staining (t = 5.108, p \ 0.0001; Fig 2d) .
Effects of DERM-SAP infusion on calbindin immunoreactivity in the striatum
An unpaired t test revealed that infusion of DERM-SAP into striatum did not significantly alter the mean density of calbindin immunoreactive staining relative to animals infused with unconjugated SAP (t = 0.5110, p = 0.6160; data not shown). Infusion of DERM-SAP into striatum also did not significantly alter the total area of calbindin immunoreactivity relative to SAP-infused animals (t = 0.5526, p = 0.5877).
Effects of DERM-SAP infusion on ChAT immunoreactivity in the striatum
An unpaired t test revealed that infusion of DERM-SAP into striatum did not significantly alter the number of ChATimmunoreactive particles relative to animals infused with unconjugated SAP (t = 0.3160, p = 0.7547; data not shown).
Effects of intrastriatal infusion of DERM-SAP on METH-induced behaviors
Acute treatment of METH initially resulted in a period of markedly increased locomotor activity for the first 40-50 min after treatment which was then followed by a sustained period of markedly increased stereotyped behavior and spatial confinement (Fig. 3a-c) .
A two-way analysis of variance of the AUC values for stereotyped behavior scores during the 2 h observation period revealed a significant main effect for DERM-SAP pretreatment (F 1,22 = 10.81, p = 0.0034), METH treatment (F 1,22 = 713.0, p \ 0.0001), and a significant interaction of pretreatment 9 treatment (F 1,22 = 6.853, p = 0.0157). Post-hoc analysis revealed that METH treatment significantly increased stereotyped behavior in both SAP (p \ 0.05) and DERM-SAP (p \ 0.05) pretreated animals; however, the METH-induced increase in stereotyped behavior was significantly lower in DERM-SAP-pretreated animals than in SAP-pretreated animals (p \ 0.05). DERM-SAP pretreatment alone did not significantly affect stereotyped behavior in saline-treated animals (p [ 0.05).
A two-way analysis of variance of the AUC values for spatial confinement scores during the 2 h observation period revealed a significant main effect for DERM-SAP pretreatment (F 1,22 = 8.668, p = 0.0075), METH treatment (F 1,22 = 194.4, p \ 0.0001), and a significant interaction of pretreatment 9 treatment (F 1,22 = 5.357, p = 0.0304). Post-hoc analysis revealed that METH treatment significantly increased spatial confinement in both SAP (p \ 0.05) and DERM-SAP (p \ 0.05) pretreated animals; however, the METH-induced increase in spatial confinement was significantly lower in DERM-SAP-pretreated animals than in SAP-pretreated animals (p \ 0.05). DERM-SAP pretreatment alone did not significantly affect spatial confinement in saline-treated animals (p [ 0.05).
A two-way analysis of variance of the AUC values for locomotor activity scores during the 2 h observation period revealed a significant main effect for DERM-SAP pretreatment (F 1,22 = 4.520, p = 0.0450), METH treatment (F 1,22 = 89.17, p \ 0.0001), and a significant interaction of pretreatment 9 treatment (F 1,22 = 6.360, p = 0.0194). Post-hoc analysis revealed that METH treatment significantly increased locomotor activity in both SAP (p \ 0.05) and DERM-SAP (p \ 0.05) pretreated animals; however, the METH-induced increase in locomotor activity was significantly greater in DERM-SAP-pretreated animals than in SAP-pretreated animals (p \ 0.05). DERM-SAP pretreatment alone did not significantly affect horizontal activity in saline-treated animals (p [ 0.05).
Effects of DERM-SAP pretreatment on METHinduced c-Fos immunoreactivity in the patch and matrix compartments of striatum
Ablation of the patch compartment appeared to prevent METH-induced increases in c-Fos immunoreactive particles in the patch compartment of the striatum, but enhanced METH-induced increases in c-Fos immunoreactive particles in the matrix of the striatum (Fig. 4a) . Semi-quantitative analysis of c-Fos immunoreactivity in the patch compartment of the striatum, followed by a two-way analysis of variance, revealed significant main effects of DERM-SAP pretreatment (F 1,18 = 27.44, p \ 0.0001), METH treatment (F 1,18 = 14.48, p = 0.0013), and a significant pretreatment 9 treatment interaction (F 1,18 = 35.87, p \ 0.0001; Fig. 4b ). Post-hoc analyses revealed that in DERM-SAPpretreated animals, METH treatment did not significantly increase the number of c-Fos immunoreactive particles/mm 2 in the patch compartment, relative to DERM-SAP-pretreated, saline-treated animals (p [ 0.05), and that in DERM-SAP-pretreated animals, there were significantly fewer c-Fos immunoreactive particles/mm 2 in the patch compartment following METH treatment, as compared to SAP-pretreated, METH-treated animals (p \ 0.05). METH treatment significantly increased the number of c-Fos immunoreactive particles/mm 2 in the patch compartment of SAP-pretreated animals (p \ 0.05), and DERM-SAP pretreatment alone did not significantly alter the number of c-Fos immunoreactive particles/mm 2 in the patch compartment (p \ 0.05).
Semi-quantitative analysis of c-Fos immunoreactivity in the matrix of the striatum, followed by a two-way analysis of variance, revealed significant main effects of DERM-SAP pretreatment (F 1,16 = 13.58, p = 0.0020), METH treatment (F 1,16 = 11.08, p = 0.0043), and a significant pretreatment 9 treatment interaction (F 1,16 = 5.372, p = 0.0340; Fig. 4c ). Post-hoc analyses revealed that METH treatment significantly increased the number of c-Fos immunoreactive particles/mm 2 in the matrix compartment of DERM-SAPpretreated animals, as compared to DERM-SAP-pretreated, saline-treated animals (p \ 0.05), and that METH treatment significantly increased the number of c-Fos immunoreactive particles/mm 2 in the matrix of DERM-SAP-pretreated animals, as compared to SAP-pretreated, METH-treated animals (p \ 0.05). METH treatment significantly increased the number of c-Fos immunoreactive particles/mm 2 in the matrix compartment of SAP-pretreated animals (p \ 0.05), and DERM-SAP pretreatment alone significantly increased the number of c-Fos-immunoreactive particles/mm 2 in the matrix compartment (p \ 0.05).
Effects of DERM-SAP pretreatment on METHinduced c-Fos immunoreactivity in the NAc
Semi-quantitative analysis of c-Fos immunoreactivity in the NAc core revealed a significant main effect for METH treatment ( 
Effects of DERM-SAP pretreatment on METH-induced c-Fos immunoreactivity in the substantia nigra
Administration of METH following the partial ablation of the patch compartment appeared to increase c-Fos immunoreactive particles in the SNpc, but decrease c-Fos immunoreactive particles in the SNpr (Fig. 5a) . Semiquantitative analysis of c-Fos immunoreactivity in the SNpc, followed by a two-way analysis of variance, revealed significant main effects of DERM-SAP pretreatment (F 1,16 = 39, p \ 0.0001), METH treatment (F 1,16 = 16, p = 0.0011), and a significant pretreatment 9 treatment interaction (F 1,16 = 18, p = 0.0006; Fig. 5b ). Post-hoc analyses revealed that METH treatment significantly increased SNpc c-Fos immunoreactivity in DERM-SAPpretreated animals, as compared to DERM-SAP-pretreated, saline-treated animals (p \ 0.05) and that METH treatment significantly increased SNpc c-Fos immunoreactivity in DERM-SAP-pretreated animals, as compared to SAPpretreated, METH-treated animals (p \ 0.05). METH treatment did not have a significant effect on SNpc c-Fos immunoreactivity in SAP-pretreated animals (p [ 0.05), nor did DERM-SAP pretreatment significantly alter c-Fos immunoreactivity in saline-treated animals (p [ 0.05).
Semi-quantitative analysis of c-Fos immunoreactivity in the SNpr, followed by a two-way analysis of variance, revealed significant main effects of DERM-SAP pretreatment (F 1,15 = 8, p = 0.013), METH treatment (F 1,15 = 32, p \ 0.0001), and a significant pretreatment 9 treatment interaction (F 1,15 = 6.5, p = 0.02; Fig. 5c ). Post-hoc analyses revealed that METH treatment significantly decreased SNpr c-Fos immunoreactivity in DERM-SAP-pretreated animals, as compared to DERM-SAP-pretreated, saline-treated animals (p \ 0.05) and that METH treatment significantly decreased SNpr c-Fos immunoreactivity in DERM-SAP-pretreated animals, as compared to SAP-pretreated, METH-treated animals (p \ 0.05). METH treatment did not have a significant effect on SNpr c-Fos immunoreactivity in SAP-pretreated Effects of DERM-SAP pretreatment on METH-induced c-Fos immunoreactivity in the medial prefrontal and sensorimotor cortices Administration of METH following the partial ablation of the patch compartment appeared to increase c-Fos immunoreactive particles in medial prefrontal, but not sensorimotor cortex (SMC) (Fig. 6a) . Semi-quantitative analysis of c-Fos immunoreactivity in the mPFC, followed by a two-way analysis of variance, revealed significant main effects of DERM-SAP pretreatment (F 1,19 = 26, p \ 0.0001), METH treatment (F 1,19 = 9.1, p = 0.007), and a significant pretreatment 9 treatment interaction (F 1,19 = 15, p = 0.001; Fig. 6b ). Post-hoc analyses revealed that METH treatment significantly increased medial prefrontal c-Fos immunoreactivity in DERM-SAP-pretreated animals, as compared to DERM-SAP-pretreated, saline-treated animals (p \ 0.05) and that METH treatment significantly increased medial prefrontal c-Fos immunoreactivity in DERM-SAP-pretreated animals, as compared to SAP-pretreated, METHtreated animals (p \ 0.05). METH treatment did not have a significant effect on medial prefrontal c-Fos immunoreactivity in SAP-pretreated animals (p [ 0.05), nor did DERM-SAP pretreatment significantly alter c-Fos immunoreactivity in saline-treated animals (p [ 0.05).
Semi-quantitative analysis of c-Fos immunoreactivity in the sensorimotor sub-region of frontal cortex, followed by a (Fig. 6c) .
Effects of DERM-SAP pretreatment on METHinduced zif/268 mRNA expression in the medial prefrontal and sensorimotor cortices Administration of METH following the partial ablation of the patch compartment appeared to increase zif/268 mRNA expression in medial prefrontal, but not SMC (Fig. 7a) . Two-way analysis of the effects of DERM-SAP pretreatment on METH-induced zif/268 mRNA expression in the mPFC revealed a significant main effect of DERM-SAP pretreatment (F 1,18 = 19.25, p \ 0.0004), METH treatment (F 1,18 = 24.2, p = 0.0001), and a significant pretreatment 9 treatment interaction (F 1,12 = 5.68, p = 0.03; Fig. 7b ). Post-hoc analyses revealed that METH treatment significantly increased medial prefrontal zif/268 mRNA expression in DERM-SAP-pretreated animals, as compared to DERM-SAP-pretreated, saline-treated animals (p \ 0.05) and that METH treatment significantly increased medial prefrontal zif/268 mRNA expression in DERM-SAP-pretreated animals, as compared to SAP-pretreated, METH-treated animals (p \ 0.05). METH treatment did not have a significant effect on medial prefrontal zif/268 mRNA expression in SAP-pretreated animals (p [ 0.05); however, DERM-SAP pretreatment significantly increased basal zif/268 expression (p \ 0.05).
Two-way analysis of variance of the effects of DERM-SAP pretreatment on zif/268 mRNA expression in the sensorimotor sub-region of frontal cortex did not reveal a (Fig. 7c) .
Discussion
The goal of the current study was to determine whether perturbation of the patch compartment would have an impact on METH-induced behaviors and alter immediate early gene expression in the striatum, substantia nigra, and frontal cortex in response to METH treatment. Intrastriatal infusion of the neurotoxin DERM-SAP resulted in a 60-70 % reduction in the size, total area and mean density of mu opioid receptor-labeled patches in the striatum. Lesions of the patch compartment resulted in a significant decrease in METH-induced stereotypic behavior and spatial confinement, while significantly increasing horizontal activity in response to METH treatment. Ablation of the patch compartment prevented induction of c-Fos by METH in this region, and enhanced METH-induced c-Fos expression in the matrix compartment of striatum. In addition, ablation of the patch compartment enhanced METH-induced c-Fos expression in the SNpc, while diminishing METH-induced c-Fos expression in the SNpr. Finally, destruction of the patch compartment potentiated METH-induced c-Fos and zif/268 mRNA expression in medial prefrontal, but not SMC. These data are among the first to specifically demonstrate a role for the patch compartment in the development of METH-induced stereotypy, indicating that preferential activation of the patch-based limbic circuits that traverse the striatum is necessary for the development of intense and focused repetitive behaviors, which is in contrast with the notion that enhanced activation of the patch compartment may serve as a homeostatic mechanism to counteract overstimulation of nigrostriatal dopaminergic neurons by psychostimulants and dampen stereotypic behaviors (Canales 2005; Saka and Graybiel 2003) . Furthermore, these data suggest that the patch compartment may provide a node of contact between the limbic system and basal ganglia, whereby internally driven states can modify and influence the motoric and adaptive behavioral functions mediated by the basal ganglia.
Previous studies indicate that treatments that result in a high level of stereotypy also induce greater relative activation of the patch compartment versus the matrix compartment, while treatments that induce a low level of stereotypy result in relatively similar levels of activation in the two compartments (Adams et al. 2003; Canales and Graybiel 2000; Graybiel et al. 1990; Horner et al. 2010 , 2012). On the other hand, sensorimotor stimulation or free movement is associated with increased activation of the matrix compartment (Brown et al. 2002; White and Hiroi 1998) and increased activation of the direct pathway, which arises primarily from the matrix compartment, contributes to the expression of psychostimulant-induced hyperlocomotor activity (Crittenden and Graybiel 2011; Fujiyama et al. 2011; Gerfen and Young 1988; Nestler 2001; Tokuno et al. 2002; Xu et al. 1994 Xu et al. , 2000 . Furthermore, the expression of stereotypy is thought to compete with locomotor activity (Aliane et al. 2009; Canales and Graybiel 2000) . Our data show that lesions of the patch compartment prior to METH treatment resulted in enhanced activation of matrix compartment, which was associated with increased locomotor activity and diminished stereotypy in METHtreated animals. In terms of how increased activity in the matrix compartment might relate to METH-induced changes in behavior, when the patch compartment is fully intact the effects of the activation of matrix-based pathways may be masked by the relatively greater activation of patchbased circuits, resulting in greater levels of stereotypy as compared to locomotor activity. On the other hand, when the patch compartment is compromised, the balance of activity tips in favor of the matrix compartment following METH treatment, leading to a greater degree of activation of the direct pathway, and increased locomotor activity. Destruction of the patch compartment and enhanced activity of the matrix compartment following METH treatment may have also contributed to the METH-induced changes in c-Fos expression in the substantia nigra. The medium spiny neurons originating in the patch compartment send GABAergic projections to the dopaminergic neurons of the SNpc (Bolam and Smith 1990; Fujiyama et al. 2011; Gerfen 1984; Jimenez-Castellanos and Graybiel 1989; Tokuno et al. 2002) and electrical stimulation of the striatum has been shown to result in a monosynaptic inhibition of these neurons (Collingridge and Davies 1981; Grace and Bunney 1985; Paladini and Tepper 1999; Tepper et al. 1990 ). Thus, it is possible that ablation of the patch compartment resulted in decreased inhibitory influence on the dopaminergic neurons of the SNpc, and may have also unmasked excitatory inputs to the SNpc, such as those from the lateral hypothalamus (Houk et al. 1995; Joel et al. 2002) , leading to enhanced c-Fos immunoreactivity in this region following METH treatment. The SNpr, on the other hand, receives GABAergic striatal inputs from the medium spiny neurons of the direct pathway (Albin et al. 1989; DeLong 1990; Gerfen and Wilson 1996) . Thus, the reduction in c-Fos immunoreactivity observed in patch-lesioned animals in the SNpr following METH treatment could reflect an increase in GABAergic striatonigral transmission, as a result of increased activation of the matrix-based direct pathway.
Immediate early genes, such as c-fos and zif/268, typically serve as indicators of neuronal activation, and also encode transcription factors that mediate the activity of other genes and are thought to be involved in neuronal plasticity, particularly the neural adaptations that occur following drug exposure (Cole et al. 1995; Knapska and Kaczmarek 2004; Unal et al. 2009; Valjent et al. 2006) . In animals treated with METH, pretreatment with DERM-SAP significantly increased both c-Fos immunoreactivity and zif/268 mRNA expression in the mPFC, but not the SMC. It is possible that enhanced METH-induced gene expression in medial prefrontal, but not SMC following patch compartment lesions, reflects an imbalance in activity in additional basal ganglia circuits. Superimposed upon the patch and matrix compartments is a medial-to-lateral topography of circuits that transverse the striatum as a whole. Specifically, circuits that transverse the dorsolateral striatum are thought to transfer sensorimotor information through the basal ganglia, while the circuits that transverse the dorsomedial striatum are thought to transfer limbicrelated information through the basal ganglia (Gerfen 1989 (Gerfen , 1992 Voorn et al. 2004 ). Interestingly, recent data indicate that during the expression of psychostimulant-induced stereotypy, there was a loss of information transmission through the limbic-related circuits that transverse the dorsomedial striatum, while information transmission through the sensorimotor circuits that transverse the dorsolateral striatum were unaltered, resulting in an imbalance in activity between the two circuits (Aliane et al. 2009 ). Since these sensorimotor and limbic-related loops through the striatum originate, and may also terminate, in the sensorimotor and medial prefrontal cortices (Alexander et al. 1986; Gerfen and Wilson 1996; Kelly and Strick 2004) , it is possible that the increased immediate early gene expression in the mPFC, relative to the SMC, could be the result of the recovery of information transmission within the medial prefrontal/dorsomedial striatal circuit, which may be associated with reduced stereotypic behavior in DERM-SAP pre-treated, METH-treated animals.
It is important to note that although our lesions were targeted to mu opioid receptor expressing neurons of the patch compartment (Herkenham and Pert 1981; Pert et al. 1976; Tempel and Zukin 1987) , a very small portion of mu opioid receptors exist on the medium spiny neurons of the matrix compartment (Guttenberg et al. 1996; Kaneko et al. 1995) , as well as on a subset of cholinergic interneurons (Jabourian et al. 2005) , raising the possibility that regions outside of the patch compartment may have been compromised by DERM-SAP treatment. However, our data indicate that both the matrix compartment and cholinergic interneurons were unaffected, as there was no decrease in calbindin or ChAT immunoreactivity following DERM-SAP treatment, which is in line with previous work (Lawhorn et al. 2009 ). It is also important to keep in mind that following DERM-SAP treatment, roughly 30 % of mu opioid receptor-labeled patches remained intact, which could explain why we failed to see a complete abolishment of METH-induced stereotypy. Furthermore, the fact that a certain degree of METH-induced stereotypy remained following perturbation of the patch compartment points to a potential contribution of extrastriatal regions such as the pedunculopontine nucleus or subthalamic nucleus to psychostimulant-induced stereotypic behavior (Aliane et al. 2012; Barwick et al. 2000; Inglis et al. 1994; Mathur et al. 1997; Pallanti et al. 2010 ). In addition, since our techniques involved one-dimensional analyses of patch density and utilized mean density of mu opioid receptor immunohistochemical staining rather than quantifying cell counts to determine the degree of patch destruction, it is possible that we were not able to fully detect the effects of DERM-SAP treatment on the patch compartment. Nevertheless, despite these potential limitations, these are among the data first to specifically examine the role of the patch compartment in METH-induced behavior and gene expression.
It is also important to note that in our hands, METH treatment alone did not significantly alter gene expression in either the substantia nigra or mPFC. These data are in conflict with previous studies where acute METH treatment increased immediate early gene expression in both of these regions (Gross and Marshall 2009; Ishida et al. 1998a, b; Shilling et al. 2006; Thiriet et al. 2001; . The reason for this discrepancy is not clear, but it could be that the dose of METH used in the current study was not high enough to produce a robust increase in gene expression, or that gene expression may have begun to wane in by the 2 h posttreatment time point utilized in our study. However, this was not a global effect, as our data showed that c-Fos expression in the striatum was significantly increased 2 h post-METH treatment. Alternatively, since gene expression in the substantia nigra and mPFC was not significantly altered following exposure to a dose of METH that induces stereotypy, these regions may not directly contribute to the genesis of stereotypic behavior, while the patch compartment, which shows robust activation during METHinduced stereotypy, contributes more heavily to the expression of psychostimulant-induced repetitive behaviors. On the other hand, when the activity of patch-based circuits in the striatum are diminished, this may result in downstream changes in the activity of these regions in response to METH treatment that represents the effect of altering overall striatal output rather than reflecting the role that the substantia nigra and prefrontal cortex play in the development of repetitive behaviors.
In summary, our study is among the first to use a targeted neurotoxin to specifically lesion the patch compartment to elucidate the role of this region in the development of METH-induced stereotyped behaviors. The current data demonstrate that the patch compartment must be intact in order for maximal expression of stereotypy in response to a single, high dose of METH, indicating that activation of limbic-associated, patch-based circuits contributes to psychostimulant-induced repetitive behaviors. Lesions of the patch compartment also increased METH-induced locomotor activity and augmented METHinduced activation of the matrix compartment, indicating that in the absence of enhanced activation of the patch compartment, the matrix-based circuits that mediate locomotor activity are unmasked, resulting in decreased spatial confinement and augmented locomotor activity. Finally, lesions of the patch compartment altered immediate early gene expression in the substantia nigra and prefrontal cortex, suggesting that patch-based circuits may influence striatal output, which results in downstream changes in activity in the basal ganglia and associated regions. Together, these data indicate that the patch compartment is an important component of the basal ganglia circuitry that mediates repetitive behaviors, and suggests that when the activity of this region is enhanced as a result of METH exposure, internally driven motivational states may override ongoing adaptive behaviors, leading to focused stereotypy and possibly maladaptive habitual behaviors.
